Brief Reports
Copyright ©The Author(s) 2004.
World J Gastroenterol. Oct 1, 2004; 10(19): 2878-2882
Published online Oct 1, 2004. doi: 10.3748/wjg.v10.i19.2878
Table 1 Pre-TACE plasma VEGF levels in patients categorized by radiological parameters
GroupNo. of patientsMedian plasma VEGF (ng/L)Statistic valueP value
Cirrhotic liverNo1380.15t = 1.3800.175
Yes3257.19
Tumor locationLeft lobe477.82F = 0.2750.843
Right lobe2666.62
Spiegel’s lobe550.38
Multiple lobe1057.68
Tumor capsuleNo3268.15t = 0.8880.379
Yes1353.18
AscitesNo3762.81t = 1.1510.280
Yes882.60
Lymph node involvementNo3961.68t = 1.6770.101
Yes6101.31
Tumor vascularityHypervascularity3175.59F = 0.9220.406
Median955.31
Hypovascularity339.1
Tumor size< 5 cm727.57F = 5.8040.006
5-10 cm2255.59
> 10 cm11101.54
Portal vein thrombosisNo3757.97t = 2.6690.011
Yes8104.79
Extra hepatic metastasisNo3959.39t = 2.4830.017
Yes6116.18
TNM classificationStage II1636.55F = 2.9370.044
Stage III1271.23
Stage IVa1179.72
Stage IVb692.63
Arterio-portal vein shuntingNo3756.03t = 2.2830.026
Yes899.9
Table 2 Effect of different VEGF levels on specificity and sensitivity in predicting tumor load in patients with HCC
Cut-off VEGFSensitivitySpecificityPositiveNegative predictive
value (ng/L)(%)(%)predictive value (%)value (%)
T II and T III/IV36.5575.962.578.658.8
Portal vein thrombosis57.9762.564.927.888.8
Extra hepatic metastasis59.395064.117.689.3
Arterio-portal vein shunting56.037567.633.392.6
Table 3 Correlation between plasma VEGF concentration and response to treatment
Clinical responsePlasma VEGF (ng/L)No. of patients
Low VEGFHigh VEGF
Responder49.52 ± 25.33t = 2.285162χ2 = 5.599
Non-responder73.33 ± 70.32P = 0.0251512P = 0.018